 | • レポートコード：C9J10935 • 出版社/出版日：Prof Research / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：化学・材料 |
| Single User | ￥450,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥570,000 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥750,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界及び中国におけるエボザック市場について調査・分析したレポートで、エボザックの世界市場動向、市場規模、主要企業情報などが含まれています。エボザックの種類別・用途別に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。 ・エボザック産業の概要 ・エボザックの製造技術分析 ・主要企業分析：企業概要、製品情報、連絡先など ・世界及び中国のエボザック市場 2014年-2019年 ・世界及び中国のエボザック市場現状 ・企業別分析：Pfizer, Novartis AG, AstraZeneca PLC, Akorn, Inc., Genexine, Bristol-Myers Squibb Company, Enzon Pharmaceuticals, Marsala Biotech, Takeda Pharmaceutical Company Limited, Fujifilm Kyowa Kirin Biologicsなど ・地域別分析：アメリカ、ヨーロッパ、日本、中国など ・種類別分析、用途別分析 ・世界及び中国のエボザック市場予測 2019年-2024年 ・エボザックの産業チェーン分析 ・世界及び中国のマクロ経済動向と影響 ・世界及び中国のエボザック市場動向・課題・機会 ・新規プロジェクトへの提言・結論 |
Evoxac Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Evoxac industry with a focus on the Chinese market. The report provides key statistics on the market status of the Evoxac manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Evoxac market covering all important parameters.
The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Evoxac industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Evoxac industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Evoxac Industry before evaluating its feasibility.
There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.
For competitor segment, the report includes global key players of Evoxac as well as some small players. At least 10 companies are included:
* Pfizer
* Novartis AG
* AstraZeneca PLC
* Akorn
* Genexine
* Bristol-Myers Squibb Company
For complete companies list, please ask for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Evoxac market in gloabal and china.
* Product Type I
* Product Type II
* Product Type III
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Application I
* Application II
* Application III
Reasons to Purchase this Report:
* Estimates 2019-2024 Evoxac market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Chapter One Introduction of Evoxac Industry
1.1 Brief Introduction of Evoxac
1.2 Development of Evoxac Industry
1.3 Status of Evoxac Industry
Chapter Two Manufacturing Technology of Evoxac
2.1 Development of Evoxac Manufacturing Technology
2.2 Analysis of Evoxac Manufacturing Technology
2.3 Trends of Evoxac Manufacturing Technology
Chapter Three Analysis of Global Key Manufacturers
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Novartis AG
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 AstraZeneca PLC
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Akorn
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Genexine
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Bristol-Myers Squibb Company
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Enzon Pharmaceuticals
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……
Chapter Four 2014-2019 Global and Chinese Market of Evoxac
4.1 2014-2019 Global Capacity, Production and Production Value of Evoxac Industry
4.2 2014-2019 Global Cost and Profit of Evoxac Industry
4.3 Market Comparison of Global and Chinese Evoxac Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Evoxac
4.5 2014-2019 Chinese Import and Export of Evoxac
Chapter Five Market Status of Evoxac Industry
5.1 Market Competition of Evoxac Industry by Company
5.2 Market Competition of Evoxac Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Evoxac Consumption by Application/Type
Chapter Six 2019-2024 Market Forecast of Global and Chinese Evoxac Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Evoxac
6.2 2019-2024 Evoxac Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Evoxac
6.4 2019-2024 Global and Chinese Supply and Consumption of Evoxac
6.5 2019-2024 Chinese Import and Export of Evoxac
Chapter Seven Analysis of Evoxac Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry
Chapter Eight Global and Chinese Economic Impact on Evoxac Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Evoxac Industry
Chapter Nine Market Dynamics of Evoxac Industry
9.1 Evoxac Industry News
9.2 Evoxac Industry Development Challenges
9.3 Evoxac Industry Development Opportunities
Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment
Chapter Eleven Research Conclusions of Global and Chinese Evoxac Industry
Tables and Figures
Figure Evoxac Product Picture
Table Development of Evoxac Manufacturing Technology
Figure Manufacturing Process of Evoxac
Table Trends of Evoxac Manufacturing Technology
Figure Evoxac Product and Specifications
Table 2014-2019 Evoxac Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Evoxac Capacity Production and Growth Rate
Figure 2014-2019 Evoxac Production Global Market Share
Figure Evoxac Product and Specifications
Table 2014-2019 Evoxac Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Evoxac Capacity Production and Growth Rate
Figure 2014-2019 Evoxac Production Global Market Share
Figure Evoxac Product and Specifications
Table 2014-2019 Evoxac Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Evoxac Capacity Production and Growth Rate
Figure 2014-2019 Evoxac Production Global Market Share
Figure Evoxac Product and Specifications
Table 2014-2019 Evoxac Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Evoxac Capacity Production and Growth Rate
Figure 2014-2019 Evoxac Production Global Market Share
Figure Evoxac Product and Specifications
Table 2014-2019 Evoxac Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Evoxac Capacity Production and Growth Rate
Figure 2014-2019 Evoxac Production Global Market Share
Figure Evoxac Product and Specifications
Table 2014-2019 Evoxac Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Evoxac Capacity Production and Growth Rate
Figure 2014-2019 Evoxac Production Global Market Share
Figure Evoxac Product and Specifications
Table 2014-2019 Evoxac Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Evoxac Capacity Production and Growth Rate
Figure 2014-2019 Evoxac Production Global Market Share
Figure Evoxac Product and Specifications
Table 2014-2019 Evoxac Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Evoxac Capacity Production and Growth Rate
Figure 2014-2019 Evoxac Production Global Market Share
……
……
Table 2014-2019 Global Evoxac Capacity List
Table 2014-2019 Global Evoxac Key Manufacturers Capacity Share List
Figure 2014-2019 Global Evoxac Manufacturers Capacity Share
Table 2014-2019 Global Evoxac Key Manufacturers Production List
Table 2014-2019 Global Evoxac Key Manufacturers Production Share List
Figure 2014-2019 Global Evoxac Manufacturers Production Share
Figure 2014-2019 Global Evoxac Capacity Production and Growth Rate
Table 2014-2019 Global Evoxac Key Manufacturers Production Value List
Figure 2014-2019 Global Evoxac Production Value and Growth Rate
Table 2014-2019 Global Evoxac Key Manufacturers Production Value Share List
Figure 2014-2019 Global Evoxac Manufacturers Production Value Share
Table 2014-2019 Global Evoxac Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Evoxac Production
Table 2014-2019 Global Supply and Consumption of Evoxac
Table 2014-2019 Import and Export of Evoxac
Figure 2018 Global Evoxac Key Manufacturers Capacity Market Share
Figure 2018 Global Evoxac Key Manufacturers Production Market Share
Figure 2018 Global Evoxac Key Manufacturers Production Value Market Share
Table 2014-2019 Global Evoxac Key Countries Capacity List
Figure 2014-2019 Global Evoxac Key Countries Capacity
Table 2014-2019 Global Evoxac Key Countries Capacity Share List
Figure 2014-2019 Global Evoxac Key Countries Capacity Share
Table 2014-2019 Global Evoxac Key Countries Production List
Figure 2014-2019 Global Evoxac Key Countries Production
Table 2014-2019 Global Evoxac Key Countries Production Share List
Figure 2014-2019 Global Evoxac Key Countries Production Share
Table 2014-2019 Global Evoxac Key Countries Consumption Volume List
Figure 2014-2019 Global Evoxac Key Countries Consumption Volume
Table 2014-2019 Global Evoxac Key Countries Consumption Volume Share List
Figure 2014-2019 Global Evoxac Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Evoxac Consumption Volume Market by Application
Table 89 2014-2019 Global Evoxac Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Evoxac Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Evoxac Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Evoxac Consumption Volume Market by Application
Figure 2019-2024 Global Evoxac Capacity Production and Growth Rate
Figure 2019-2024 Global Evoxac Production Value and Growth Rate
Table 2019-2024 Global Evoxac Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Evoxac Production
Table 2019-2024 Global Supply and Consumption of Evoxac
Table 2019-2024 Import and Export of Evoxac
Figure Industry Chain Structure of Evoxac Industry
Figure Production Cost Analysis of Evoxac
Figure Downstream Analysis of Evoxac
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Evoxac Industry
Table Evoxac Industry Development Challenges
Table Evoxac Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Evoxacs Project Feasibility Study
世界のスニチニブ薬市場：市場規模・現状・予測 Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…- 世界のバレニクリン市場：市場規模・現状・予測 Varenicline (trade name Chantix and Champix), is a prescription medication used to treat nicotine addiction. It reduces both craving for and decreases the pleasurable effects of cigarettes and other tobacco products.In 2018, the global Varenicline market size was xx million US$ and it is expected to…
- 世界のDNAワクチン接種市場：市場規模・現状・予測 DNA vaccination is a technique for protecting against disease by injection with genetically engineered DNA so cells directly produce an antigen, producing a protective immunological response.In 2018, the global DNA Vaccination market size was xx million US$ and it is expected to reach xx million US$…
- 世界のトラコーマ治療市場：市場規模・現状・予測 Trachoma is an infectious disease caused by bacterium Chlamydia trachomatis. The infection causes a roughening of the inner surface of the eyelids.In 2018, the global Trachoma Treatments market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% …
- 世界の髄膜炎菌感染症の治療市場：市場規模・現状・予測 Meningococcal meningitis are a major cause of bacterial meningitis and septicemia, usually occurs during infancy, adolescence and young adulthood and is characterized by an infectious syndrome with meningismus. Aggressive early treatment of meningococcal disease can reduce mortality.In 2018, the glo…